It ain’t getting to a dollar even if it gets approved in October-Nov time frame, which appears highly unlikely at this point. No reimbursement or commercial preparation. Why would it get valued at $1.5B or even $1B for a tiny UK market without any reimbursement support or commercial preparedness. Forget about a $1. We’d be super lucky at this point if it hits .50! The only reason that would happen is because shorts and hedge funds would want to short again from a higher base.
Market Data 
Markets 
AI
